HPV+ cervical carcinomas and cell lines display altered expression of caspases

Gynecologic Oncology

Volumn 108, Issue 1, 2008, Pages 10-18

  Aréchaga Ocampo, Elena ^a   Pereira Suárez, Ana Laura ^b   del Moral Hernández, Oscar ^a   Cedillo Barrón, Leticia ^a   Rodríguez Sastre, Maria Alexandra ^c   Castillo Álvarez, Aída ^a   López Bayghen, Esther ^a   Villegas Sepúlveda, Nicolás ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DEL ESTADO DE HIDALGO   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cervical carcinoma; Effector Caspases; Initiator Caspases; Pro caspases

Indexed keywords

CASPASE; CASPASE 3; CASPASE 9;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; E6 ONCOGENE; E7 ONCOGENE; FEMALE; HELA CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; NEWBORN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX EPITHELIUM; WART VIRUS; WESTERN BLOTTING;

ADENOCARCINOMA; BLOTTING, WESTERN; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CASPASES; CELL LINE, TUMOR; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; PAPILLOMAVIRUS INFECTIONS; PARAFFIN EMBEDDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 37349086781     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.08.070     Document Type: Article

References (55)

1. Green D.R., and Evan G.I. A matter of life and death. Cancer Cell 1 (2002) 19-30
2. Pisani P., Bray F., and Parkin D.M. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97 (2002) 72-81
3. zur Hausen H. Papillomavirus infections: a major cause of human cancers. Biochim Biophys Acta 1288 (1996) F55-F78
4. Munger K., and Howley P.M. Human papillomavirus immortalization and transformation function. Virus Res 89 (2002) 213-228
5. Stanley M.A. Human papillomavirus and cervical carcinogenesis. Best Pract Res Clin Obstet Gynaecol 15 (2001) 663-676
6. Herrington C.S. Human papillomaviruses and cervical neoplasia: II. Interaction of HPV with other factors. J Clin Pathol 48 (1995) 1-6
7. Loeb L.A., Loeb K.R., and Anderson J.P. Multiple mutations and cancer. Proc Natl Acad Sci U S A 100 (2003) 776-781
8. Mullauer L., Gruber P., Sebinger D., Buch J., Wohlfart S., and Chott A. Mutations in apoptosis genes: a pathogenetic factor for human disease. Mutat Res 488 (2001) 211-231
9. Zörnig M., Hueber A.O., Baum W., and Evan G. Apoptosis regulators and their role in tumorigenesis. Biochim Biophys Acta 1551 (2001) F1-F37
10. Sheets E.E., and Yeh J. The role of apoptosis in gynaecological malignancies. Ann Med 29 (1997) 121-126
11. Nair P., Nair K.M., Jayaprakash P.G., and Pillai M.R. Decreased programmed cell death in the uterine cervix associated with high risk human papillomavirus infection. Pathol Oncol Res 5 (1999) 95-103
12. Padilla L.A., Leung B.S., and Carson L.F. Evidence of an association between human papillomavirus and impaired chemotherapy-induced apoptosis in cervical cancer cells. Gynecol Oncol 85 (2002) 59-66
13. + cervical carcinoma cells to CD95-mediated apoptosis. Int J Cancer 93 (2001) 823-831
14. Hougardy M.T.B., van der Zee A.G.T., van den Heuvel F.A.J., Timmer T., de Vries E.G.E., and de Jong S. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase 8 and Bid. Gynecol Oncol 97 (2005) 353-364
15. Ledwaba T., Dlamini Z., Naicker S., and Bhoola K. Molecular genetics of human cervical cancer: role of papillomavirus and the apoptotic cascade. Biol Chem 385 (2004) 671-682
16. Garnett T.O., and Duerksen-Hughes P.J. Modulation of apoptosis by human papillomavirus (HPV) oncoproteins. Arch Virol 151 (2006) 2321-2335
17. Wolf B.B., and Green D.R. Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem 274 (1999) 20049-20052
18. Alnemri E.S., Livingston D.J., Nicholson D.W., Salvesen G., Thornberry N.A., Wong W.W., and Yuan J. Human ICE/CED-3 protease nomenclature. Cell 87 (1996) 171
19. Ramage P., Cheneval D., Chvei M., Graff P., Hemmig R., Heng R., Kocher H.P., Mackenzie A., Memmert K., Revesz L., and Wishart W. Expression, refolding and autocatalytic proteolytic processing of the interleukin-1 beta-converting enzyme precursor. J Biol Chem 270 (1995) 9378-9383
20. Yamin T.T., Ayala J.M., and Miller D.K. Activation of the native 45-kDa precursor form of interleukin-1-converting enzyme. J Biol Chem 22 (1996) 13273-13282
21. Earnshaw W.C., Martins L.M., and Kaufmann S.H. Mammalian Caspases: structure, activation, substrates and functions during apoptosis. Annu Rev Biochem 68 (1996) 383-424
22. Sun X.M., MacFarlane M., Zhuang J., Wolf B.B., Green D.R., and Cohen G.M. Distinct caspase cascades are initiated in receptors-mediated and chemical-induced apoptosis. J Biol Chem 274 (1999) 5053-5060
23. Slee E.A., Adrain C., and Martin S.J. Executioner caspase-3, -6 and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem 276 (2001) 7320-7326
24. Philchenkov A., Zavelevich M., Kroczak T.J., and Los M. Caspases and cancer: mechanisms of inactivation and new treatment modalities. Exp Oncol 26 (2004) 82-97
25. Faderl S., Thall F.P., Kantarjian H.M., Talpaz M., Harris D., Van Q., et al. Caspase 2 and Caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia. Clin Cancer Res 5 (1999) 4041-4047
26. Teitz T., Wei T., Valentine M.B., Vanin E.F., Grenet J., Valentine V.A., et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 6 (2000) 529-535
27. Eggert A., Grotzer M.A., Zuzak T.J., Wiewrodt B.R., Ho R., Ikegaki N., et al. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase 8 expression. Cancer Res 61 (2001) 1314-1319
28. Muris J.J., Cillessen S.A., Vos W., van Houdt I.S., Kummer J.A., van Krieken J.H., et al. Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas. Blood 105 (2005) 2916-2923
29. Poulaki V., Mitsiades C.S., McMullan C., Fanourakis G., Negri J., Goudopoulou A., et al. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase 8 gene silencing. Invest Ophthalmol Vis Sci 46 (2005) 358-366
30. Virkajärvi N., Pääkkö P., and Soini Y. Apoptotic index and apoptosis influencing proteins bcl-2, mcl-1 and caspases 3, 6 and 8 in pancreatic carcinoma. Histopathology 33 (1990) 432-439
31. Joseph B., Ekedahl J., Sirzen F., Lewensohn R., and Zhivotovsky B. Differences in expression of pro-caspases in small cell and non-small cell lung carcinoma. Biochem Biophys Res Commun 262 (1999) 381-387
32. Winter R.N., Kramer A., Brokowski A., and Kyprianou N. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res 61 (2001) 1227-1232
33. Devarajan E., Sahin A.A., Chen J.S., Krishnamurthy R.R., Aggarwal N., Brun A.M., et al. Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene 21 (2002) 8843-8851
34. Yoo J.N., Kim H.S., Kim S.Y., Park W.S., Kim S.H., Lee J.Y., et al. Stomach cancer highly expresses both initiator and effector caspases; an immunohistochemical study. APMIS 110 (2002) 825-832
35. Chung T.K.H., Cheung T.H., Lo W.K., Yim S.F., Yu M.Y., Krajewski S., et al. Expression of apoptotic regulators and their significances in cervical cancer. Cancer Lett 180 (2002) 63-68
36. Cheung T.H., Chung T.K.H., Lo W.K., Yu M.Y., Krajewski S., Redd J.C., et al. Apoptosis-related proteins in cervical intraepithelial neoplasia and squamous cell carcinoma of the cervix. Gynecol Oncol 86 (2002) 14-18
37. Zanotti S., Fisseler-Eckhoff A., and Mannherz H.G. Changes in the topological expression of markers of differentiation and apoptosis in defined stages of human cervical dysplasia and carcinoma. Gynecol Oncol 89 (2003) 376-384
38. Filippova M., Johnson M.M., Bautista M., Filippov V., Fodor N., Tungteakkhun S.S., et al. The large and small isoforms of HPV 16 E6 bind to and differentially affect procaspase 8 stability and activity. J Virol 81 (2007) 4116-4129
39. Rheinwald J.G., and Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6 (1975) 331-343
40. Mannos M.M., Ting Y., Wright D.K., Lewis A.J., Broker T.R., and Wolinsky S.M. Use of polymerase chain reaction amplification for detection of genital human papillomaviruses. Cancer Cells 7 (1989) 209-214
41. Guido M., Zamorano R., Garrido-Guerrero E., Gariglio P., and García-Carrancá A. Early promoters of genital and cutaneous human papillomaviruses are differentially regulated by the bovine papillomavirus type 1 E2 gene product. J Gen Virol 73 (1992) 1395-1400
42. Holleman A., den Boer M.L., Kazemier K.M., Beverloo H.B., von Bergh A.R., Janka-Schaub G.E., et al. Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia. Blood 106 (2005) 1817-1823
43. Henle G., and Deinhardt FJ. The establishment of strains of human cells in tissue culture. J Immunol 79 (1957) 54-59
44. Friedl F., Kimura I., Osato T., and Ito Y. Studies on a new human cell line (SiHa) derived from carcinoma of uterus. Its establishment and morphology. Proc Soc Exp Biol Med 135 (1970) 543-545
45. Pattillo R.A., Hussa R.O., Story M.T., Ruckert A.C., Shalaby M.R., and Mattingly R.F. Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Science 196 (1977) 1456-1458
46. Auersperg N. Long-term cultivation of hypodiploid human tumor cells. J Natl Cancer Inst 32 (1964) 135-148
47. Kaufmann S.H., and Vaux D.L. Alterations in the apoptotic machinery and their potential role in anticancer drug resistance. Oncogene 22 (2003) 7414-7430
48. Sasai K., Yajima H., and Suzuki F. Suppression of postmitochondrial signalling and delayed response to UV-induced nuclear apoptosis in HeLa cells. Jpn J Cancer Res 93 (2002) 275-283
49. Grote P., Schaeuble K., and Ferrando-May E. Commuting (to) suicide: an update on nucleocytoplasmic transport in apoptosis. Arch Biochem Biophys 462 (2007) 156-161
50. Ferrando-May E. Nucleocytoplasmic transport in apoptosis. Cell Death Differ 12 (2005) 1263-1276
51. Xerri L., Palmerini F., Devilard E., Defrance T., Bouabdallah R., Hassoun J., and Birg F. Frequent nuclear localization of ICAD and cytoplasmic co-expression of caspase-8 and caspase-3 in human lymphomas. J Pathol 192 (2000) 194-202
52. Yasuhara N., Eguchi Y., Tachibana T., Imamoto N., Yoneda Y., and Tsujimoto Y. Essential role of active nuclear transport in apoptosis. Genes Cells 2 (1997) 55-64
53. Ramuz O., Isnardon D., Devilard E., Charafe-Jauffret E., Hassoun J., Birg F., et al. Constitutive nuclear localization and initiate cytoplasmic apoptotic activation of endogenous caspase-3 evidence by confocal microscopy. Int J Exp Pathol 84 (2003) 75-81
54. Liu J.R., Opipari A.W., Tan L., Jiang Y., Zhang Y., Tang H., et al. Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance. Cancer Res 62 (2002) 924-931
55. Harada K., Toyooka S., Shivapurkar N., Maitra A., Reddy J.L., Matta H., et al. Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. Cancer Res 62 (2002) 5897-5901